Re: Comments on 'High-intensity statins are associated with improved clinical activity of programmed cell death protein 1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients'

Eur J Cancer. 2021 Aug:153:267-269. doi: 10.1016/j.ejca.2021.05.016. Epub 2021 Jun 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Immune Checkpoint Inhibitors
  • Lung Neoplasms* / drug therapy
  • Mesothelioma* / drug therapy
  • Mesothelioma, Malignant*
  • Pleural Neoplasms* / drug therapy

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Immune Checkpoint Inhibitors